Eris Lifesciences Share Price
1274.60+4.70 (+0.37%)
-22.04% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
ERISNSE
Eris Lifesciences Share Price
1274.60+4.70 (+0.37%)
-22.04% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| 18% | 21% | 23% | 8% |
| 17% | 12% | 17% | 73% |
| - | 11% | 16% | -22% |
| 27% | 18% | 17% | 19% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
ERIS
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,849.9 | ₹447476 Cr | 37 | 12.07 | 62.82 | ₹11479 Cr |
| 9,602 | ₹254764 Cr | 87.1 | 34.04 | 128.41 | ₹2568 Cr |
| 4,928.5 | ₹189423 Cr | 86.85 | 16.72 | 97.06 | ₹2163 Cr |
| 1,180.3 | ₹116658 Cr | 25.85 | 9.42 | 62.53 | ₹5040 Cr |
| 1,399 | ₹111484 Cr | 33.08 | 9.77 | 57.87 | ₹3879 Cr |
| 2,026.2 | ₹109943 Cr | 100.55 | 6.8 | 29.25 | ₹889 Cr |
| 2,500 | ₹101712 Cr | 49.79 | 13.75 | 71.08 | ₹1913 Cr |
| 1,200.4 | ₹101005 Cr | 31.35 | 5.32 | 63.99 | ₹4196 Cr |
| 1,716 | ₹99253 Cr | 26.73 | 17.95 | 96.84 | ₹3505 Cr |
| 2,100.7 | ₹96031 Cr | 17.37 | 30.95 | 154.35 | ₹5333 Cr |
| 1,275 | ₹17618 Cr | 27.36 | 10.27 | 66.67 | ₹620 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 L | ₹14 L | ₹14 L | ₹14 L | ₹14 L |
| ₹14 Cr | ₹10 Cr | ₹5 Cr | ₹3 Cr | ₹2 Cr | ₹4 Cr | ₹3 Cr | ₹1 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹3875 Cr | ₹2831 Cr | ₹2568 Cr | ₹2180 Cr | ₹1893 Cr | ₹1559 Cr | ₹1280 Cr | ₹1136 Cr | ₹848 Cr | ₹553 Cr | ₹299 Cr | ₹266 Cr | ₹177 Cr | ₹106 Cr | ₹48 Cr |
| ₹3875 Cr | ₹2831 Cr | ₹2568 Cr | ₹2180 Cr | ₹1893 Cr | ₹1559 Cr | ₹1280 Cr | ₹1136 Cr | ₹848 Cr | ₹553 Cr | ₹299 Cr | ₹266 Cr | ₹177 Cr | ₹106 Cr | ₹48 Cr |
| ₹3903 Cr | ₹2854 Cr | ₹2586 Cr | ₹2196 Cr | ₹1908 Cr | ₹1576 Cr | ₹1296 Cr | ₹1151 Cr | ₹861 Cr | ₹567 Cr | ₹300 Cr | ₹266 Cr | ₹177 Cr | ₹106 Cr | ₹48 Cr |
| -₹7 Cr | ₹417 Cr | ₹636 Cr | ₹25 Cr | -₹11 L | ₹20,000 | ₹0 | ₹18 Cr | ₹25 Cr | ₹24 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹5 Cr |
| ₹956 Cr | ₹1738 Cr | ₹655 Cr | ₹644 Cr | ₹45 Cr | ₹0 | ₹0 | ₹29 L | ₹274 Cr | ₹49 L | ₹0 | ₹50 L | ₹0 | ₹56 L | ₹3 Cr |
| ₹62 Cr | ₹229 Cr | ₹227 Cr | -₹16 Cr | -₹197 Cr | -₹151 Cr | -₹120 Cr | -₹93 Cr | -₹48 Cr | -₹15 Cr | -₹6 Cr | -₹3 Cr | -₹21 L | -₹26 L | ₹2 L |
| ₹45 Cr | ₹55 Cr | ₹45 Cr | ₹57 Cr | ₹41 Cr | ₹11 Cr | ₹15 Cr | ₹8 Cr | ₹3 Cr | ₹4 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr |
| ₹87 Cr | ₹79 Cr | ₹53 Cr | ₹45 Cr | ₹32 Cr | ₹31 Cr | ₹26 Cr | ₹19 Cr | ₹19 Cr | ₹23 Cr | ₹23 Cr | ₹20 Cr | ₹17 Cr | ₹15 Cr | ₹9 Cr |
| ₹1150 Cr | ₹2101 Cr | ₹979 Cr | ₹730 Cr | -₹79 Cr | -₹109 Cr | -₹80 Cr | -₹65 Cr | ₹248 Cr | ₹12 Cr | ₹20 Cr | ₹19 Cr | ₹18 Cr | ₹17 Cr | ₹14 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹330 Cr | ₹332 Cr | ₹219 Cr | ₹125 Cr | ₹118 Cr | ₹103 Cr | ₹100 Cr | ₹84 Cr | ₹91 Cr | ₹39 Cr | ₹25 Cr | ₹37 Cr | ₹37 Cr | ₹22 Cr | ₹18 Cr |
| ₹1178 Cr | ₹534 Cr | ₹900 Cr | ₹190 Cr | ₹36 Cr | ₹29 Cr | ₹27 Cr | ₹199 Cr | ₹115 Cr | ₹14 Cr | ₹10 Cr | ₹8 Cr | ₹15 Cr | ₹9 Cr | ₹5 Cr |
| ₹454 Cr | ₹397 Cr | ₹1311 Cr | ₹55 Cr | ₹1 L | ₹1 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹240 Cr | ₹230 Cr | ₹179 Cr | ₹151 Cr | ₹130 Cr | ₹104 Cr | ₹93 Cr | ₹95 Cr | ₹88 Cr | ₹77 Cr | ₹35 Cr | ₹21 Cr | ₹19 Cr | ₹13 Cr | ₹12 Cr |
| ₹2201 Cr | ₹1493 Cr | ₹2609 Cr | ₹521 Cr | ₹283 Cr | ₹235 Cr | ₹220 Cr | ₹377 Cr | ₹294 Cr | ₹129 Cr | ₹69 Cr | ₹65 Cr | ₹71 Cr | ₹44 Cr | ₹35 Cr |
| ₹7247 Cr | ₹6866 Cr | ₹6810 Cr | ₹3472 Cr | ₹2113 Cr | ₹1703 Cr | ₹1437 Cr | ₹1481 Cr | ₹1428 Cr | ₹732 Cr | ₹392 Cr | ₹354 Cr | ₹270 Cr | ₹172 Cr | ₹102 Cr |
| ₹52 Cr | ₹52 Cr | ₹54 Cr | ₹28 Cr | ₹25 Cr | ₹20 Cr | ₹17 Cr | ₹17 Cr | ₹14 Cr | ₹13 Cr | ₹59 L | ₹90 L | ₹59 L | ₹5 L | ₹5 L |
| ₹2310 Cr | ₹2422 Cr | ₹2735 Cr | ₹830 Cr | ₹45 Cr | ₹1 L | ₹0 | ₹176 Cr | ₹377 Cr | ₹65 L | ₹50 L | ₹1 Cr | ₹53 L | ₹3 Cr | ₹5 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹6162 Cr | ₹6061 Cr | ₹4773 Cr | ₹2843 Cr | ₹1092 Cr | ₹1006 Cr | ₹984 Cr | ₹838 Cr | ₹820 Cr | ₹254 Cr | ₹123 Cr | ₹104 Cr | ₹91 Cr | ₹39 Cr | ₹32 Cr |
| ₹974 Cr | ₹754 Cr | ₹454 Cr | ₹275 Cr | ₹174 Cr | ₹152 Cr | ₹109 Cr | ₹78 Cr | ₹48 Cr | ₹23 Cr | ₹52 Cr | ₹32 Cr | ₹17 Cr | ₹12 Cr | ₹9 Cr |
| ₹5188 Cr | ₹5306 Cr | ₹4319 Cr | ₹2568 Cr | ₹918 Cr | ₹854 Cr | ₹875 Cr | ₹761 Cr | ₹771 Cr | ₹232 Cr | ₹71 Cr | ₹72 Cr | ₹75 Cr | ₹27 Cr | ₹23 Cr |
| ₹171 Cr | ₹67 Cr | ₹19 Cr | ₹21 Cr | ₹24 Cr | ₹0 | ₹0 | ₹75 L | ₹0 | ₹7 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹62 Cr | ₹62 Cr | ₹16 Cr | ₹7 Cr | ₹421 Cr | ₹244 Cr | ₹3 Cr | ₹41 Cr | ₹272 Cr | ₹213 Cr | ₹63 Cr | ₹97 Cr | ₹17 Cr | ₹70,000 | ₹60,000 |
| ₹62 Cr | ₹62 Cr | ₹16 Cr | ₹7 Cr | ₹421 Cr | ₹244 Cr | ₹3 Cr | ₹41 Cr | ₹272 Cr | ₹213 Cr | ₹63 Cr | ₹97 Cr | ₹17 Cr | ₹70,000 | ₹60,000 |
| ₹152 Cr | ₹88 Cr | ₹70 Cr | ₹25 Cr | ₹36 Cr | ₹26 Cr | ₹16 Cr | ₹17 Cr | ₹12 Cr | ₹13 Cr | ₹35 Cr | ₹21 Cr | ₹23 Cr | ₹18 Cr | ₹9 Cr |
| ₹10 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹0 | ₹42 Cr | ₹3 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹5583 Cr | ₹5531 Cr | ₹4431 Cr | ₹2629 Cr | ₹1402 Cr | ₹1167 Cr | ₹902 Cr | ₹827 Cr | ₹1061 Cr | ₹463 Cr | ₹169 Cr | ₹190 Cr | ₹115 Cr | ₹45 Cr | ₹33 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹0 | ₹5 Cr | ₹0 | ₹30 Cr | ₹100 Cr | ₹50 Cr | ₹75 Cr | ₹315 Cr | ₹94 Cr | ₹90 Cr | ₹127 Cr | ₹69 Cr | ₹67 Cr | ₹47 Cr | ₹13 Cr |
| ₹437 Cr | ₹335 Cr | ₹189 Cr | ₹131 Cr | ₹118 Cr | ₹94 Cr | ₹69 Cr | ₹83 Cr | ₹65 Cr | ₹56 Cr | ₹48 Cr | ₹58 Cr | ₹45 Cr | ₹43 Cr | ₹23 Cr |
| ₹680 Cr | ₹459 Cr | ₹422 Cr | ₹293 Cr | ₹161 Cr | ₹140 Cr | ₹157 Cr | ₹84 Cr | ₹67 Cr | ₹49 Cr | ₹25 Cr | ₹24 Cr | ₹22 Cr | ₹17 Cr | ₹14 Cr |
| ₹67 Cr | ₹223 Cr | ₹1401 Cr | ₹58 Cr | ₹52 Cr | ₹38 Cr | ₹67 Cr | ₹8 Cr | ₹11 Cr | ₹2 Cr | ₹10 Cr | ₹6 Cr | ₹7 Cr | ₹5 Cr | ₹9 Cr |
| ₹44 Cr | ₹26 Cr | ₹32 Cr | ₹22 Cr | ₹24 Cr | ₹36 Cr | ₹55 Cr | ₹58 Cr | ₹44 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹89 L | ₹40 L |
| ₹435 Cr | ₹287 Cr | ₹335 Cr | ₹308 Cr | ₹256 Cr | ₹176 Cr | ₹111 Cr | ₹107 Cr | ₹86 Cr | ₹68 Cr | ₹10 Cr | ₹5 Cr | ₹11 Cr | ₹14 Cr | ₹9 Cr |
| ₹1664 Cr | ₹1334 Cr | ₹2379 Cr | ₹843 Cr | ₹711 Cr | ₹536 Cr | ₹535 Cr | ₹653 Cr | ₹367 Cr | ₹269 Cr | ₹222 Cr | ₹163 Cr | ₹155 Cr | ₹126 Cr | ₹69 Cr |
| -₹537 Cr | -₹158 Cr | -₹230 Cr | ₹321 Cr | ₹428 Cr | ₹300 Cr | ₹315 Cr | ₹276 Cr | ₹73 Cr | ₹140 Cr | ₹153 Cr | ₹98 Cr | ₹84 Cr | ₹83 Cr | ₹34 Cr |
| ₹7247 Cr | ₹6866 Cr | ₹6810 Cr | ₹3472 Cr | ₹2113 Cr | ₹1703 Cr | ₹1437 Cr | ₹1481 Cr | ₹1428 Cr | ₹732 Cr | ₹392 Cr | ₹354 Cr | ₹270 Cr | ₹172 Cr | ₹102 Cr |
| ₹281 | ₹209 | ₹190 | ₹161 | ₹140 | ₹116 | ₹95 | ₹84 | ₹63 | ₹41 | ₹21,712 | ₹19,279 | ₹12,818 | ₹7,688 | ₹3,470 |
| ₹281 | ₹209 | ₹190 | ₹161 | ₹140 | ₹116 | ₹95 | ₹84 | ₹63 | ₹41 | ₹22 | ₹19 | ₹13 | ₹8 | ₹3 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹639 Cr | ₹489 Cr | ₹431 Cr | ₹405 Cr | ₹442 Cr | ₹394 Cr | ₹331 Cr | ₹317 Cr | ₹312 Cr | ₹270 Cr | ₹154 Cr | ₹109 Cr | ₹98 Cr | ₹83 Cr | ₹55 Cr |
| ₹482 Cr | ₹548 Cr | ₹254 Cr | ₹140 Cr | ₹49 Cr | ₹44 Cr | ₹44 Cr | ₹31 Cr | ₹14 Cr | -₹65 L | ₹20 Cr | ₹12 Cr | ₹69 L | ₹7 Cr | ₹3 Cr |
| -₹458 Cr | ₹126 Cr | -₹99 Cr | -₹176 Cr | -₹30 Cr | ₹5 Cr | -₹53 Cr | -₹53 Cr | -₹22 Cr | -₹16 Cr | -₹8 Cr | -₹8 Cr | ₹21 Cr | -₹16 Cr | -₹11 Cr |
| ₹662 Cr | ₹1163 Cr | ₹587 Cr | ₹369 Cr | ₹462 Cr | ₹444 Cr | ₹323 Cr | ₹295 Cr | ₹304 Cr | ₹253 Cr | ₹166 Cr | ₹113 Cr | ₹120 Cr | ₹74 Cr | ₹48 Cr |
| ₹538 Cr | ₹1065 Cr | ₹486 Cr | ₹292 Cr | ₹378 Cr | ₹375 Cr | ₹271 Cr | ₹223 Cr | ₹235 Cr | ₹200 Cr | ₹131 Cr | ₹90 Cr | ₹90 Cr | ₹38 Cr | ₹30 Cr |
| -₹369 Cr | -₹80 Cr | -₹1855 Cr | -₹982 Cr | -₹320 Cr | -₹323 Cr | ₹123 Cr | -₹5 Cr | -₹590 Cr | -₹184 Cr | -₹44 Cr | -₹92 Cr | -₹83 Cr | -₹36 Cr | -₹19 Cr |
| -₹314 Cr | -₹881 Cr | ₹1380 Cr | ₹688 Cr | -₹45 Cr | -₹82 Cr | -₹335 Cr | -₹221 Cr | ₹363 Cr | -₹24 Cr | -₹84 Cr | ₹46 L | -₹2 Cr | -₹3 Cr | -₹10 Cr |
| -₹145 Cr | ₹104 Cr | ₹11 Cr | -₹2 Cr | ₹14 Cr | -₹30 Cr | ₹60 Cr | -₹3 Cr | ₹8 Cr | -₹8 Cr | ₹4 Cr | -₹2 Cr | ₹5 Cr | -₹77 L | ₹100 L |
| ₹200 Cr | ₹94 Cr | ₹56 Cr | ₹51 Cr | ₹37 Cr | ₹67 Cr | ₹8 Cr | ₹11 Cr | ₹2 Cr | ₹9 Cr | ₹5 Cr | ₹7 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr |
| ₹0 | ₹2 Cr | ₹27 Cr | ₹7 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹52 L | ₹1 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹55 Cr | ₹200 Cr | ₹94 Cr | ₹56 Cr | ₹51 Cr | ₹37 Cr | ₹67 Cr | ₹8 Cr | ₹11 Cr | ₹2 Cr | ₹9 Cr | ₹5 Cr | ₹7 Cr | ₹2 Cr | ₹3 Cr |
Fundamental Ratios
Consolidated
Standalone
Eris Lifesciences Share Price
1274.60+4.70 (+0.37%)
-22.04% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 4
Bearish signals: 5 out of 9 oscillators
RSI
36.27Sell
STOCH %K
11.18Buy
MACD Level(12,26)
-18.18Sell
Ultimate Oscillator
35.73Sell
Aroon Oscillator
-94.00Sell
BOP
0.44Buy
CCI
-157.18Buy
Williams %R
-88.82Buy
Momentum
-28.90Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 0
Bearish signals: 9 out of 9 moving averages
EMA 9
1294.51Sell
SMA 9
1301.31Sell
EMA 21
1311.88Sell
SMA 21
1309.59Sell
EMA 50
1340.69Sell
SMA 50
1353.47Sell
EMA 200
1402.63Sell
SMA 200
1397.94Sell
WMA 20
1305.74Sell
Pivot
Pivot
Classic
Resistance 5
1355.97
Resistance 4
1335.37
Resistance 3
1314.77
Resistance 2
1294.17
Resistance 1
1282.03
Pivot
1273.57
Support 1
1261.43
Support 2
1252.97
Support 3
1232.37
Support 4
1211.77
Support 5
1191.17
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Eris Lifesciences Share Price
1274.60+4.70 (+0.37%)
-22.04% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| 54.14% | 53.92% | 54.85% | 54.85% | 54.83% | 54.85% |
| 5.76% | 6.39% | 6.85% | 7.21% | 8.39% | 8.43% |
| 1.83% | 2.13% | 2.05% | 2.03% | 1.40% | 1.48% |
| 18.88% | 18.22% | 18.26% | 17.33% | 16.78% | 16.59% |
| 19.39% | 19.34% | 17.99% | 18.58% | 18.60% | 18.65% |
Bulk & block deals
Name
Motilal Oswal Financial Services Limited
Rakesh Shah
Infinity Partners
Emerald Investments Limited
Infinity Partners
Emerald Investments Limited
Franklin Templeton Mutual Fund
Rakesh Shah
Bhikhalal Chimanlal Shah
Bhikhalal Chimanlal Shah
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 03 Oct 2024 | Purchase | 280.70 Cr | ₹1,350.18 | 20.79 L | Bulk | 1.498501 | NSE |
| 03 Oct 2024 | Sell | 270 Cr | ₹1,350 | 20 L | Bulk | 1.44156 | NSE |
| 22 Aug 2024 | Purchase | 1,187.41 Cr | ₹1,201 | 98.87 L | Bulk | 7.126266 | NSE |
| 22 Aug 2024 | Sell | 1,187.41 Cr | ₹1,201 | 98.87 L | Bulk | 7.126266 | NSE |
| 22 Aug 2024 | Purchase | 1,187.41 Cr | ₹1,201 | 98.87 L | Block | 7.126266 | NSE |
| 22 Aug 2024 | Sell | 1,187.41 Cr | ₹1,201 | 98.87 L | Block | 7.126266 | NSE |
| 15 Jul 2024 | Purchase | 109.42 Cr | ₹1,000.04 | 10.94 L | Bulk | 0.788678 | NSE |
| 15 Jul 2024 | Sell | 200.02 Cr | ₹1,000.12 | 20 L | Bulk | 1.44156 | NSE |
| 31 Jan 2024 | Sell | 116.88 Cr | ₹913.09 | 12.80 L | Bulk | 0.922598 | BSE |
| 31 Jan 2024 | Sell | 74.83 Cr | ₹912.50 | 8.20 L | Bulk | 0.59104 | NSE |
Insider trading & SAST
Client name
Infinity Partners
Emerald Investments Ltd
Lilac Investments Ltd
Infinity Partners
Hdfc Mutual Fund
Uti Mutual Fund & Pacs
Uti Mutual Fund & Pacs
Uti Mutual Fund
Uti Mutual Fund
Hdfc Mutual Fund
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29 Aug 2024 | Other | Acquisition | 7.27 | 7.27 | 0 | — | 98.87 L | 22 Aug 2024 | Market / Inter-se Transfer | 98,86,882 | SAST | 29(1) | — |
| 29 Aug 2024 | Other | Disposal | 7.27 | — | 0 | — | 98.87 L | 22 Aug 2024 | Market | — | SAST | 29(2) | — |
| 29 Aug 2024 | Other | Acquisition | 7.27 | 7.27 | 0 | — | 98.87 L | 22 Aug 2024 | Off Market | 98,86,882 | SAST | 29(1) | — |
| 29 Aug 2024 | Other | Disposal | 7.27 | — | 0 | — | 98.87 L | 22 Aug 2024 | Off Market | — | SAST | 29(2) | — |
| 16 May 2024 | Other | Acquisition | 2 | 7.13 | 0 | — | 27.21 L | 14 May 2024 | Market | 96,96,364 | SAST | 29(2) | — |
| 08 May 2024 | Other | Disposal | 0.02 | 4.98 | 0 | — | 28 K | 03 May 2024 | Market | 67,79,886 | SAST | 29(2) | — |
| 13 Feb 2024 | Other | Acquisition | 0.05 | 5.02 | 0 | — | 74.88 K | 07 Feb 2024 | Market | 68,32,640 | SAST | 29(1) | — |
| 09 Feb 2024 | Other | Acquisition | 0.05 | 5.02 | 0 | — | 75 K | 07 Feb 2024 | Market | 68,32,640 | SAST | 29(1) | — |
| 04 Jan 2024 | Other | Disposal | 0.1 | 4.98 | 0 | — | 1.40 L | 19 Dec 2023 | Market | 67,86,730 | SAST | 29(2) | — |
| 04 Jan 2024 | Other | Acquisition | 0.15 | 5.13 | 0 | — | 2 L | 15 Dec 2023 | Market | 69,75,299 | SAST | 29(1) | — |
Eris Lifesciences Share Price
1274.60+4.70 (+0.37%)
-22.04% past 1 Year
Eris Lifesciences Limited founded by Amit Bakshi and team in 2007 is one of the fastest growing companies within the chronic and acute categories of the Indian Branded Formulations market
Corporate Actions
Date
Type
Details
Company details
Eris Lifesciences Share Price
1274.60+4.70 (+0.37%)
-22.04% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Eris Lifesciences Share Price
1274.60+4.70 (+0.37%)
-22.04% past 1 Year
News
Eris Lifesciences COO Krishna Kumar Vaidyanathan steps down
Equity
ERIS
Eris Lifesciences to meet analysts and investors on August 27
Equity
ERIS
Eris Lifesciences Q1 EBITDA margin below long-term FY27 guidance range
Equity
ERIS
Eris Lifesciences Q1 revenue grows 13 percent, below FY27 guidance pace
Equity
ERIS
Eris Lifesciences Q1 FY earnings show EBITDA growth but margin compression
Equity
ERIS
Eris Lifesciences reports strong Q1 revenue growth on year-over-year basis
Equity
ERIS
Eris Lifesciences Q1 consolidated net profit rises 16.7 percent year-on-year
Equity
ERIS
Eris Lifesciences sets ambitious FY27 revenue growth and margin targets
Equity
ERIS
Eris Lifesciences - Quaterly Results
Equity
ERIS
Eris Lifescience guides FY27 revenue growth at 18 to 20 percent
Equity
ERIS
Eris Lifesciences issues FY27 revenue growth guidance of 18-20 percent
Equity
ERIS
Eris Lifesciences reports Profit after tax of Rs -8.60 Crores, in the March 2026 quarter
Equity
ERIS
Eris Lifesciences Q4 FY26 EBITDA grows with marginal improvement in margins
Equity
ERIS
Eris Lifesciences posts year-on-year revenue growth in Q4 earnings update
Equity
ERIS
Eris Lifesciences Q4 consolidated net profit surges sharply year-on-year
Equity
ERIS
Eris Lifesciences informs about allotment of equity shares
Equity
ERIS
Eris Lifesciences informs about newspaper publication
Equity
ERIS
Macquarie Retains Outperform on Eris Lifesciences with Rs 1,680 Target Post Halmed GMP Inspection.
Equity
ERIS
Macquarie Flags Unresolved Observations Slowing Eris Lifesciences CDMO Progress
Equity
ERIS
Eris Lifesciences Faces Halmed Inspection Flags on Swiss Units for Non-Compliance.
Equity
ERIS

